Drugs in Clinical Trials

Research in the burgeoning drug market continues to expand, with pharmaceutical and drug companies constantly exploring and testing new compounds for the treatment of new and existing conditions and indications. This unique directory covers approximately 1,900 cutting-edge drugs across 400 disease conditions that are currently in clinical development worldwide. Patients and their advocates can use the Directory to identify potentially life-saving treatments not yet available in pharmacies or on the market. Entries on each experimental drug typically include its name, manufacturer, description and the drug's current research phase. Though the final outcome of the clinical trials is unknown, The CenterWatch Directory of Drugs in Clinical Trials offers the most detailed information to date on these compounds. Coverage in this edition includes 600 new drugs, including many in pediatric trials and Phase I testing, and has been expanded to include NDA information. The Directory includes indexes allowing quick access to information by indication for treatment, by manufacturer and by scientific or trade name.
ISBN: 978-1-930624-18-4

Zobacz wszystkie książki autora: brak danych.